Plandai Biotechnology, Inc. (PLPL) Announces Buy Recommendation from Murphy Analytics
Today before the opening bell, Plandai Biotechnology announced that Murphy Analytics, LLC has initiated coverage and issued a buy recommendation with a twelve month price potential of $2.20 per share. According to Murphy Analytics, the positive potential valuation reflects the current value of plantation holdings of Plandai, the global market for green tea and green tea extracts, the profit projections prepared by Plandai, and the trading value of companies within the industry. Plandai CEO Roger Duffield commented, "Murphy Analytics has a great reputation and we're pleased to see recognition of the market potential for Plandai's technology. As we shift our…